UVB Phototherapy Treatment of Oral Chronic GVHD
NCT00374257 · Status: TERMINATED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 11
Last updated 2025-12-19
Summary
The purpose of this trial is to find out how effective Narrow Band-Ultraviolet Light B (NB-UVB) phototherapy is in treating oral cGVHD. NB-UVB Phototherapy involves exposing the inside of the mouth to light of a particular spectrum (a specific wavelength of light, 311nm) of the ultraviolet band, called NB-UVB. It is known that narrow band ultraviolet light therapy can improve symptoms in patients with skin chronic GVHD.
Conditions
- Oral Chronic Graft-versus-host Disease
Interventions
- PROCEDURE
-
Narrow-Band UVB Phototherapy
Performed either two or three times per week for a total of 24 treatments
Sponsors & Collaborators
- collaborator OTHER
-
Brigham and Women's Hospital
lead OTHER
Principal Investigators
-
Nathaniel S. Treister, DMD, DMSc · Brigham and Women's Hospital
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 4 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-08-31
- Primary Completion
- 2008-09-30
- Completion
- 2008-09-30
Countries
- United States
Study Locations
More Related Trials
-
Photodynamic Therapy System for Patients With Refractory/Unresponsive Solid Tumors
NCT00028405 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG
NCT01730417 ·Status: COMPLETED ·Phase: PHASE1
-
Statin Therapy in Young Adult Survivors of Childhood Cancer
NCT01733953 ·Status: COMPLETED ·Phase: PHASE2
-
Trial of Pentoxifylline in Patients With Functional Disability Caused by Radiation-Induced Advanced Regional Fibrosis
NCT00001437 ·Status: COMPLETED ·Phase: PHASE2
-
Multivitamins do Not Improve Radiation Therapy Related Fatigue
NCT00383409 ·Status: COMPLETED ·Phase: PHASE2
-
Functional and Molecular Characterization of Treatment Response in Tumors in the Oral Cavity Using Optical Spectroscopy
NCT04272294 ·Status: WITHDRAWN ·Phase: NA
-
Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors
NCT00925275 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Immunogenicity and Pharmacokinetics of ONC-841
NCT06219499 ·Status: WITHDRAWN ·Phase: PHASE1
-
Determining Whether Intra-Arterial Carboplatin Causes Hearing Loss in Children
NCT03866460 ·Status: COMPLETED
-
Multicentre Real-life Data Collection Study With CareMin650™ in the Prevention and Treatment of Oral Mucositis and Radio- and/or Chemo-induced Dermatitis
NCT07054528 ·Status: ACTIVE_NOT_RECRUITING
-
Radiation Therapy Plus Topotecan in Treating Patients With Non-small Cell Lung Cancer
NCT00002537 ·Status: COMPLETED ·Phase: PHASE1
-
Oral NRX 194204 in Patients With Refractory Malignancies
NCT00630760 ·Status: TERMINATED ·Phase: PHASE1
-
Assessing Insulin Sensitivity and Diabetes Risk in Childhood Cancer Survivors Treated With Abdominal Irradiation
NCT02248779 ·Status: COMPLETED
-
Benzoylphenylurea in Treating Patients With Advanced Cancer
NCT00010205 ·Status: TERMINATED ·Phase: PHASE1
-
PDT Plus Vitamin D3 for Anal Dysplasia
NCT02698293 ·Status: WITHDRAWN ·Phase: PHASE1
-
Symptom Burden in Head and Neck Cancer
NCT01219673 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Pharmacokinetics of Daunorubicin in Young Patients With Cancer
NCT00673257 ·Status: COMPLETED ·Phase: NA
-
A Virtual Intervention to Improve Medication Adherence in Pediatric Cancer: MedSupport
NCT05150028 ·Status: COMPLETED ·Phase: NA
-
Molecular Signature of Valproic Acid in Breast Cancer With Functional Imaging Assessment - a Pilot
NCT01007695 ·Status: TERMINATED ·Phase: PHASE1
-
Impact of a Monitoring Device for Patients With Cancer Treated Using Oral Therapeutics
NCT02828462 ·Status: UNKNOWN
-
A Phase I Study Of Oral Topotecan And Lapatinib In Subjects With Advanced Solid Tumors
NCT00682279 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Single-Radiolabeled Dose Mass Balance Study To Investigate The Absorption, Metabolism, And Excretion Of [14C] Palbociclib (PD-0332991) In Healthy Male Volunteers
NCT01756768 ·Status: COMPLETED ·Phase: PHASE1
-
Radiation Therapy, Chemotherapy, and Soy Isoflavones in Treating Patients With Stage IIIA-IIIB Non-Small Cell Lung Cancer
NCT01958372 ·Status: COMPLETED ·Phase: PHASE1
-
CFI-402257, a Potent and Selective TTK Inhibitor, in Solid Tumors and With Fulvestrant in Breast Cancer
NCT05251714 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2
-
Chemoprevention Trial for Uremia-Associated Urothelial Carcinoma
NCT00172367 ·Status: WITHDRAWN ·Phase: PHASE2